Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Autoimmune Disorders

  Free Subscription


11.09.2017

3 Ann Neurol
3 BMC Neurol
4 Diabetes
1 Intern Med
1 J Immunol
1 J Nephrol
1 J Neuroimmunol
1 J Neurol
3 J Pediatr
4 J Rheumatol
1 Lancet Psychiatry
1 Mult Scler
1 Neurology
28 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Neurol

  1. MONTGOMERY S, Hiyoshi A, Burkill S, Alfredsson L, et al
    Concussion in adolescence and risk of multiple sclerosis.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25036.
    PubMed     Text format     Abstract available

  2. ZAHEDNASAB H, Harirchian MH, Karampoor S, Keyvani H, et al
    MMP-9 as a biomarker of PML development in MS patients receiving Natalizumab.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25037.
    PubMed     Text format    

  3. FISSOLO N, Pignolet B, Brassat D, Comabella M, et al
    Reply: MMP-9 as a biomarker of PML development in MS patients receiving Natalizumab.
    Ann Neurol. 2017 Sep 4. doi: 10.1002/ana.25039.
    PubMed     Text format    


    BMC Neurol

  4. DRIEDGER SM, Maier R, Marrie RA, Brouwers M, et al
    Caught in a no-win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists - a qualitative study.
    BMC Neurol. 2017;17:176.
    PubMed     Text format     Abstract available

  5. KLEITER I, Lang M, Jeske J, Norenberg C, et al
    Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT(R) autoinjector: a prospective observational cohort study.
    BMC Neurol. 2017;17:174.
    PubMed     Text format     Abstract available

  6. ZECCA C, Disanto G, Muhl S, Gobbi C, et al
    Subjective patient-reported versus objective adherence to subcutaneous interferon beta-1a in multiple sclerosis using RebiSmart(R): the CORE study.
    BMC Neurol. 2017;17:171.
    PubMed     Text format     Abstract available


    Diabetes

  7. THELIN MA, Kissler S, Vigneault F, Watters AL, et al
    In Vivo Enrichment of Diabetogenic T Cells.
    Diabetes. 2017 Apr 10. pii: db160946. doi: 10.2337/db16-0946.
    PubMed     Text format     Abstract available

  8. HERNANDEZ R, Graves SA, Gregg T, VanDeusen HR, et al
    Radiomanganese PET Detects Changes in Functional beta-cell Mass in Mouse Models of Diabetes.
    Diabetes. 2017 May 17. pii: db161285. doi: 10.2337/db16-1285.
    PubMed     Text format     Abstract available

  9. HAMED S, Ullmann Y, Egozi D, Keren A, et al
    Topical Erythropoietin Treatment Accelerates the Healing of Cutaneous Burn Wounds in Diabetic Pigs Through an Aquaporin-3-Dependent Mechanism.
    Diabetes. 2017 May 25. pii: db161205. doi: 10.2337/db16-1205.
    PubMed     Text format     Abstract available

  10. HANSSEN NMJ, Scheijen JLJM, Jorsal A, Parving HH, et al
    Higher Plasma Methylglyoxal Levels are Associated with Incident Cardiovascular Disease in Individuals with Type 1 Diabetes: a 12-Year Follow-Up Study.
    Diabetes. 2017 Jun 6. pii: db161578. doi: 10.2337/db16-1578.
    PubMed     Text format     Abstract available


    Intern Med

  11. KONISHI C, Nakagawa K, Nakai E, Nishi K, et al
    Interstitial Lung Disease as an Initial Manifestation of Giant Cell Arteritis.
    Intern Med. 2017 Sep 6. doi: 10.2169/internalmedicine.8861.
    PubMed     Text format     Abstract available


    J Immunol

  12. PIKOR NB, Cupovic J, Onder L, Gommerman JL, et al
    Stromal Cell Niches in the Inflamed Central Nervous System.
    J Immunol. 2017;198:1775-1781.
    PubMed     Text format     Abstract available


    J Nephrol

  13. ANGIOI A, Lepori N, Lopez AC, Sethi S, et al
    Treatment of primary membranous nephropathy: where are we now?
    J Nephrol. 2017 Sep 5. doi: 10.1007/s40620-017-0427.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  14. ALVAREZ BRAVO G, Yusta Izquierdo A, Carvalho Monteiro G, Sanchez I, et al
    Cerebellopathy secondary to anti-peroxidase antibody-mediated toxicity. A special case of Hashimoto encephalopathy.
    J Neuroimmunol. 2017 Aug 19. pii: S0165-5728(17)30265.
    PubMed     Text format     Abstract available


    J Neurol

  15. PARDO G, Jones DE
    The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations.
    J Neurol. 2017 Sep 6. doi: 10.1007/s00415-017-8594.
    PubMed     Text format     Abstract available


    J Pediatr

  16. SPAANS E, Schroor E, Groenier K, Bilo H, et al
    Thyroid Disease and Type 1 Diabetes in Dutch Children: A Nationwide Study (Young Dudes-3).
    J Pediatr. 2017 Jun 2. pii: S0022-3476(17)30637.
    PubMed     Text format     Abstract available

  17. SEGHEZZO S, Bleesing JJ, Kucuk ZY
    Persistent Enteropathy in a Toddler with a Novel FOXP3 Mutation and Normal FOXP3 Protein Expression.
    J Pediatr. 2017;186:183-185.
    PubMed     Text format     Abstract available

  18. SARDAR E, Dusser P, Rousseau A, Bodaghi B, et al
    Retrospective Study Evaluating Treatment Decisions and Outcomes of Childhood Uveitis Not Associated with Juvenile Idiopathic Arthritis.
    J Pediatr. 2017;186:131-137.
    PubMed     Text format     Abstract available


    J Rheumatol

  19. ZOHOURY N, Bertolaccini ML, Rodriguez-Garcia JL, Shums Z, et al
    Closing the Serological Gap in the Antiphospholipid Syndrome: The Value of "Non-criteria" Antiphospholipid Antibodies.
    J Rheumatol. 2017 Sep 1. pii: jrheum.170044. doi: 10.3899/jrheum.170044.
    PubMed     Text format     Abstract available

  20. NANTES SG, Su J, Dhaliwal A, Colosimo K, et al
    Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
    J Rheumatol. 2017 Sep 1. pii: jrheum.161125. doi: 10.3899/jrheum.161125.
    PubMed     Text format     Abstract available

  21. KUMTHEKAR A, Danve A, Deodhar A
    Use of Belimumab throughout 2 Consecutive Pregnancies in a Patient with Systemic Lupus Erythematosus.
    J Rheumatol. 2017;44:1416-1417.
    PubMed     Text format    


  22. Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients.
    J Rheumatol. 2017;44:1417.
    PubMed     Text format    


    Lancet Psychiatry

  23. VOETS N
    Can functional connectivity diagnose autoantibody-associated encephalitides?
    Lancet Psychiatry. 2017 Sep 4. pii: S2215-0366(17)30366.
    PubMed     Text format    


    Mult Scler

  24. GIOVANNONI G, Soelberg Sorensen P, Cook S, Rammohan K, et al
    Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.
    Mult Scler. 2017 Aug 1:1352458517727603. doi: 10.1177/1352458517727603.
    PubMed     Text format     Abstract available


    Neurology

  25. LORSCHEIDER J, Jokubaitis VG, Spelman T, Izquierdo G, et al
    Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.
    Neurology. 2017;89:1050-1059.
    PubMed     Text format     Abstract available


    PLoS One

  26. YAN T, Ke Y, Chen Y, Xu C, et al
    Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin.
    PLoS One. 2017;12:e0174735.
    PubMed     Text format     Abstract available

  27. LLAURADO G, Cano A, Hernandez C, Gonzalez-Sastre M, et al
    Type 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance.
    PLoS One. 2017;12:e0174640.
    PubMed     Text format     Abstract available

  28. HANAOKA H, Kiyokawa T, Iida H, Ishimori K, et al
    Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.
    PLoS One. 2017;12:e0175152.
    PubMed     Text format     Abstract available

  29. DOBRAKOWSKI P, Bogocz M, Cholewa K, Rajchel M, et al
    Month of birth and level of insolation as risk factors for multiple sclerosis in Poland.
    PLoS One. 2017;12:e0175156.
    PubMed     Text format     Abstract available

  30. GIESS RM, Pfuhl C, Behrens JR, Rasche L, et al
    Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
    PLoS One. 2017;12:e0175279.
    PubMed     Text format     Abstract available

  31. HARRIS VK, Bell L, Langan RA, Tuddenham J, et al
    Fetuin-A deficiency protects mice from Experimental Autoimmune Encephalomyelitis (EAE) and correlates with altered innate immune response.
    PLoS One. 2017;12:e0175575.
    PubMed     Text format     Abstract available

  32. AYUSO T, Aznar P, Soriano L, Olaskoaga A, et al
    Vitamin D receptor gene is epigenetically altered and transcriptionally up-regulated in multiple sclerosis.
    PLoS One. 2017;12:e0174726.
    PubMed     Text format     Abstract available

  33. NEEDELL JC, Dinarello CA, Ir D, Robertson CE, et al
    Implication of the intestinal microbiome as a potential surrogate marker of immune responsiveness to experimental therapies in autoimmune diabetes.
    PLoS One. 2017;12:e0173968.
    PubMed     Text format     Abstract available

  34. MULS N, Nasr Z, Dang HA, Sindic C, et al
    IL-22, GM-CSF and IL-17 in peripheral CD4+ T cell subpopulations during multiple sclerosis relapses and remission. Impact of corticosteroid therapy.
    PLoS One. 2017;12:e0173780.
    PubMed     Text format     Abstract available

  35. HIROOKA K, Saito W, Namba K, Mizuuchi K, et al
    Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids.
    PLoS One. 2017;12:e0172612.
    PubMed     Text format     Abstract available

  36. ZAPRUTKO T, Kopciuch D, Kus K, Merks P, et al
    Affordability of medicines in the European Union.
    PLoS One. 2017;12:e0172753.
    PubMed     Text format     Abstract available

  37. FATIMA N, Faisal SM, Zubair S, Ajmal M, et al
    Role of Pro-Inflammatory Cytokines and Biochemical Markers in the Pathogenesis of Type 1 Diabetes: Correlation with Age and Glycemic Condition in Diabetic Human Subjects.
    PLoS One. 2016;11:e0161548.
    PubMed     Text format     Abstract available

  38. MURAKAMI T, Uji A, Suzuma K, Dodo Y, et al
    In Vivo Choroidal Vascular Lesions in Diabetes on Swept-Source Optical Coherence Tomography.
    PLoS One. 2016;11:e0160317.
    PubMed     Text format     Abstract available

  39. PAOLICELLI D, Iannazzo S, Santoni L, Iaffaldano A, et al
    The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
    PLoS One. 2016;11:e0159214.
    PubMed     Text format     Abstract available

  40. TALMAGE GD, Coppes OJM, Javed A, Bernard J, et al
    Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study.
    PLoS One. 2017;12:e0173299.
    PubMed     Text format     Abstract available

  41. QIAO YC, Chen YL, Pan YH, Tian F, et al
    The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0176157.
    PubMed     Text format     Abstract available

  42. MAGNUSSON K, Bech Holte K, Juel NG, Brox JI, et al
    Long term type 1 diabetes is associated with hand pain, disability and stiffness but not with structural hand osteoarthritis features - The Dialong hand study.
    PLoS One. 2017;12:e0177118.
    PubMed     Text format     Abstract available

  43. LAM HV, Nguyen DT, Nguyen CD
    Sibling method increases risk assessment estimates for type 1 diabetes.
    PLoS One. 2017;12:e0176341.
    PubMed     Text format     Abstract available

  44. VAN AALST S, Ludwig IS, van der Zee R, van Eden W, et al
    Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant.
    PLoS One. 2017;12:e0177365.
    PubMed     Text format     Abstract available

  45. SCOTT A, Chambers D, Goyder E, O'Cathain A, et al
    Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: A systematic review.
    PLoS One. 2017;12:e0177210.
    PubMed     Text format     Abstract available

  46. LI Q, Ye H, Ding Y, Chen G, et al
    Clinical characteristics of moderate-to-severe thyroid associated ophthalmopathy in 354 Chinese cases.
    PLoS One. 2017;12:e0176064.
    PubMed     Text format     Abstract available

  47. NIEGOWSKA M, Delitala A, Pes GM, Delitala G, et al
    Increased seroreactivity to proinsulin and homologous mycobacterial peptides in latent autoimmune diabetes in adults.
    PLoS One. 2017;12:e0176584.
    PubMed     Text format     Abstract available

  48. MARINO KR, Lundberg RL, Jasrotia A, Maranda LS, et al
    A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes.
    PLoS One. 2017;12:e0176860.
    PubMed     Text format     Abstract available

  49. IZQUIERDO G, Damas F, Paramo MD, Ruiz-Pena JL, et al
    The real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study.
    PLoS One. 2017;12:e0176174.
    PubMed     Text format     Abstract available

  50. XU E, Cao H, Lin L, Liu H, et al
    rs10499194 polymorphism in the tumor necrosis factor-alpha inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.
    PLoS One. 2017;12:e0176471.
    PubMed     Text format     Abstract available

  51. SCHNEIDER R, Bellenberg B, Hoepner R, Kolb EM, et al
    Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal leukoencephalopathy (PML).
    PLoS One. 2017;12:e0176415.
    PubMed     Text format     Abstract available

  52. ZHAN Z, Yang Y, Zhan Y, Chen D, et al
    Fetal outcomes and associated factors of adverse outcomes of pregnancy in southern Chinese women with systemic lupus erythematosus.
    PLoS One. 2017;12:e0176457.
    PubMed     Text format     Abstract available

  53. INGLESE M, Petracca M, Mormina E, Achiron A, et al
    Cerebellar volume as imaging outcome in progressive multiple sclerosis.
    PLoS One. 2017;12:e0176519.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  54. DO J, Kim D, Kim S, Valentin-Torres A, et al
    Treg-specific IL-27Ralpha deletion uncovers a key role for IL-27 in Treg function to control autoimmunity.
    Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201703100.
    PubMed     Text format     Abstract available

  55. HU Y, Jin S, Cheng L, Liu G, et al
    Autoimmune disease variants regulate GSDMB gene expression in human immune cells and whole blood.
    Proc Natl Acad Sci U S A. 2017 Sep 7. pii: 201712127.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: